ES2587583T3 - Método de almacenamiento de formulaciones de nanopartículas - Google Patents

Método de almacenamiento de formulaciones de nanopartículas Download PDF

Info

Publication number
ES2587583T3
ES2587583T3 ES06789920.3T ES06789920T ES2587583T3 ES 2587583 T3 ES2587583 T3 ES 2587583T3 ES 06789920 T ES06789920 T ES 06789920T ES 2587583 T3 ES2587583 T3 ES 2587583T3
Authority
ES
Spain
Prior art keywords
mpeg
dspe
agents
phosphatidylcholine
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06789920.3T
Other languages
English (en)
Spanish (es)
Inventor
Weiping Yu
John Mon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imunon Inc
Original Assignee
Celsion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celsion Corp filed Critical Celsion Corp
Application granted granted Critical
Publication of ES2587583T3 publication Critical patent/ES2587583T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
ES06789920.3T 2005-08-23 2006-08-23 Método de almacenamiento de formulaciones de nanopartículas Active ES2587583T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71015605P 2005-08-23 2005-08-23
US710156P 2005-08-23
PCT/US2006/032714 WO2007024826A2 (en) 2005-08-23 2006-08-23 Method of storing nanoparticle formulations

Publications (1)

Publication Number Publication Date
ES2587583T3 true ES2587583T3 (es) 2016-10-25

Family

ID=37441856

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06789920.3T Active ES2587583T3 (es) 2005-08-23 2006-08-23 Método de almacenamiento de formulaciones de nanopartículas

Country Status (10)

Country Link
EP (1) EP1937214B1 (ko)
JP (1) JP5227173B2 (ko)
KR (2) KR101209496B1 (ko)
CN (1) CN101282715B (ko)
AU (1) AU2006283465B2 (ko)
CA (1) CA2620829C (ko)
ES (1) ES2587583T3 (ko)
HK (1) HK1120731A1 (ko)
TW (1) TWI388344B (ko)
WO (1) WO2007024826A2 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090122479A (ko) * 2007-03-30 2009-11-30 에이전시 포 사이언스, 테크놀로지 앤드 리서치 소수성 양자점의 캡슐화
WO2009059449A1 (en) * 2007-11-05 2009-05-14 Celsion Corporation Novel thermosensitive liposomes containing therapeutic agents
US20130230457A1 (en) * 2012-02-17 2013-09-05 Celsion Corporation Thermosensitive Nanoparticle Formulations and Method of Making The Same
US11679163B2 (en) 2019-09-20 2023-06-20 Hdt Bio Corp. Compositions and methods for delivery of RNA
AU2021241355A1 (en) 2020-03-23 2022-10-13 Hdt Bio Corp. Compositions and methods for delivery of RNA
EP4404919A1 (en) * 2021-09-22 2024-07-31 HDT Bio Corp. Dried nanoparticle compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1256372A (en) * 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
KR900700079A (ko) * 1988-01-12 1990-08-11 후지하라 도미오 누출방지 리포좀 제제
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
JPH06211645A (ja) * 1993-01-14 1994-08-02 Mitsubishi Kasei Corp リポソーム凍結乾燥製剤
CA2207961A1 (en) * 1995-01-05 1996-07-11 Robert J. Levy Surface-modified nanoparticles and method of making and using same
WO1997004787A1 (en) * 1995-08-01 1997-02-13 Novartis Ag Liposomal oligonucleotide compositions
GB9609779D0 (en) * 1996-05-10 1996-07-17 Univ Bruxelles Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US6200598B1 (en) * 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
ES2225178T3 (es) * 1999-07-16 2005-03-16 Alza Corporation Composicion liposomica resistente a los daños producidos por congelacion/descongelacion.
AR036316A1 (es) * 2002-08-29 2004-08-25 Monte Verde S A Una composicion farmaceutica de liposomas de tamano pequeno y metodo de preparacion
JP4293586B2 (ja) * 2002-08-30 2009-07-08 浜松ホトニクス株式会社 ナノ粒子の製造方法及び製造装置

Also Published As

Publication number Publication date
HK1120731A1 (en) 2009-04-09
WO2007024826A2 (en) 2007-03-01
TW200803918A (en) 2008-01-16
TWI388344B (zh) 2013-03-11
CA2620829C (en) 2013-10-29
CA2620829A1 (en) 2007-03-01
KR20080046672A (ko) 2008-05-27
WO2007024826A3 (en) 2007-10-11
JP2009506038A (ja) 2009-02-12
AU2006283465A1 (en) 2007-03-01
EP1937214B1 (en) 2016-07-27
CN101282715B (zh) 2013-03-27
KR101209496B1 (ko) 2012-12-07
JP5227173B2 (ja) 2013-07-03
EP1937214A2 (en) 2008-07-02
KR20120104438A (ko) 2012-09-20
AU2006283465B2 (en) 2011-11-03
CN101282715A (zh) 2008-10-08

Similar Documents

Publication Publication Date Title
ES2272496T3 (es) Procedimiento de deshidratacion/rehidritacion para la preparacion de lipososmas.
ES2331791T5 (es) Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo
JP2022033892A (ja) 凍結乾燥リポソーム
ES2704299T3 (es) Formulaciones de liposomas multivesiculares de ácido tranexámico
ES2332584T3 (es) Metodo y composicion para solubilizar un compuesto biologicamente activo con baja solubilidad en agua.
ES2587583T3 (es) Método de almacenamiento de formulaciones de nanopartículas
PT1443900E (pt) Composições de veículo lipídico com estabilidade melhorada no sangue
CN101190188A (zh) 蒽环类药物脂质体注射剂及制备方法
US11712407B2 (en) Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
ES2275443B1 (es) Procedimiento de preparacion de liposomas.
BR112012021951B1 (pt) Bicelas encapsuladas em lipossomas e método para obtenção de lipossoma
Ramasamy et al. Nanocochleate—a new drug delivery system
ES2703750T3 (es) Formulación liposomal que contiene un compuesto activo antitumoral, método para producirla y composiciones farmacéuticas que la contiene
Gowri et al. Proniosome: a novel approach to vesicular drug delivery system
WO2011113981A1 (es) Una composición farmacéutica soluble en agua que comprende al menos una sustancia terapéuticamente activa de características hidrofóbicas y al menos un compuesto seleccionado entre los sialoglicoesfingolípidos, los glicoesfingolípidos o una mezcla de sialoglicoesfingolípidos y glicoesfingolípidos
ES2826879T3 (es) Procedimiento para la producción de vehículos lipídicos
Imanishimwe et al. Entrapment of Ibuprofen by Multilamellar Liposomes for Aerosol Drug Delivery Towards Sustained Release Upon Pulmonary Administration
Gregory Preparation of Liposomes and Oily Formulations by Freeze-Drying of Monophase Solutions
CN117897140A (zh) 用于制备脂质体制剂的方法
Li et al. Preparation of liposomes and oily formulations by freeze-drying of monophase solutions
Gregoriadis Preparation of Liposomes and Oily Formulations by Freeze-Drying of Monophase Solutions.............. ChunLei Li, YingJie Deng, and JingXia Cui
PL197938B1 (pl) Liposomowy preparat zawierający przeciwnowotworową substancję aktywną, sposób jego wytwarzania i zawierająca go kompozycja farmaceutyczna